Benefit-Risk Assessment of Medicines

Benefit-Risk Assessment of Medicines

Benefit-Risk Assessment of Medicines: The Development and Application of a Universal Framework for Decision-Making and Effective Communication By James Leong, Sam Salek, Stuart Walker
2015 | 332 Pages | ISBN: 331915804X | PDF | 18 MB

This book proposes and investigates a universal framework, and accompanying documentation system, to facilitate and catalogue benefit-risk decisions; a valuable addition to the benefit-risk toolbox.
Over the past decade, pharmaceutical companies and regulatory agencies have been reviewing the benefit-risk assessment of medicines with a view to developing a structured, systematic, standardized approach. Examining the evaluation of such an approach by several mature regulatory authorities ensures that the reader gains a unique insight into the ongoing debate in this area.
The field of benefit-risk assessment continues to evolve at a rapid pace due to political and societal pressure, as is reflected in the recent FDA PUDFA agreement as well as in the EMA 2015 Roadmap. Rather than provide a comprehensive snap-shot of this constantly changing environment, this book evaluates selected current approaches to benefit-risk assessment. The strengths and weaknesses of publicly available documents in communicating benefit-risk decisions to stakeholders are reviewed and these evaluations are used to inform development of a prospective framework that could be used to harmonise procedures globally.
Download link:

Buy Premium From My Links To Support Me & Download with MaX SPeeD!

Donate Bitcoin 1SLKcwi5VbQrpoKnXUGfBLVcj3VCWVfnQ
Donate Ether 0x032f4d361571dA8cF5602D3C73530817365052B8
0
Information
Users of Guests are not allowed to comment this publication.